Cochrane Abstracts
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer New
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) for Assessing Tumour Resectability in Advanced Epithelial Ovarian/fallopian Tube/primary Peritoneal Cancer New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438974/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer_New. Accessed 27 February 2021.
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438974/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer_New. Accessed February 27, 2021.
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438974/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer_New
Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) for Assessing Tumour Resectability in Advanced Epithelial Ovarian/fallopian Tube/primary Peritoneal Cancer New [Internet]. In: Cochrane Abstracts. [cited 2021 February 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438974/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer New
ID - 438974
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438974/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer_New
DB - Evidence Central
DP - Unbound Medicine
ER -
